With diabetes being a complex health condition, finding a cure for it naturally comes with quite a few challenges. However, scientists have recently made a huge breakthrough regarding the search for a cure by purging mice of the debilitating illness. This puts them one step closer to finally ending the suffering of thousands around the world who are living with diabetes every day.
Now, it’s worth noting that the study is still in its very early stages and there is still a lot of work to be done. However, it is encouraging to know that UT Health San Antonio researchers finally found a way to improve insulin secretion, which could potentially end insulin-dependency by diabetics, Futurism reports.
The researchers have tested their new method on lab mice that were afflicted with the disease and the rodents were cured. For one year, the subjects exhibited no symptoms to indicate that the cure did not work. Dr. Bruno Doiron, one of the researchers behind the project said as much.
“It worked perfectly,” Dr. Doiron said. “We cured mice for one year without any side effects. That’s never been seen. But it’s a mouse model, so caution is needed. We want to bring this to large animals that are closer to humans in physiology of the endocrine system.”
As a result, the researchers are now thinking about moving the cure to human trials over the next three years. That might seem like a lifetime, but it’s much closer than anyone has ever been to rid the world of diabetes.
It would seem that the obstacles won’t be much of an issue either since it would appear that the Food and Drug Administration has granted approval to similar cases in the past, News.com.au reports. If so, the world should be on track to becoming free of diabetes in the next decade or so.


Tabletop particle accelerator could transform medicine and materials science
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Neuralink Expands Brain Implant Trials with 12 Global Patients
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 



